Estrella Immunopharma Inc (ESLA)

Not featured in screeners

Not featured in screeners

Ticker: ESLA Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Estrella Immunopharma Inc

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

Buy 7 Oct 2025

Value US$594,502.31 | Price 320.03 | Shares 66,261 (+9.7%)

Buy 22 Sep 2025

Value US$304,013.40 | Price 106.35 | Shares 41,218 (-10.2%)

Buy 11 Sep 2025

Value US$104.00 | Price 1.04 | Shares 100 (+0.0%)

Buy 4 Mar 2022

Value US$44,677,959,000.00 | Price 314,700.00 | Shares 141,970 (+12.8%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-04-29	2025-10-07	B Purchase	2.9 Xu Jiandong Chief Financial Officer Officer	66,261 +9.7% 320.03 US$594,502	66,261 +9.7%	320.03	US$594,502
2026-04-29	2025-09-22	B Purchase	2.9 Xu Jiandong Chief Financial Officer Officer	41,218 -10.2% 106.35 US$304,013	41,218 -10.2%	106.35	US$304,013
2026-04-29	2025-09-11	B Purchase	2.9 Xu Jiandong Chief Financial Officer Officer	13,513 -10.0% 492.68 US$4,327,933	13,513 -10.0%	492.68	US$4,327,933
2022-03-17	2022-03-04	B Purchase	Li Jianwei Co-Chief Executive Officer Executive Director Large shareholder	141,970 +12.8% 314,700.00 US$44,677,959,000	141,970 +12.8%	314,700.00	US$44,677,959,000

More insider trading research around Estrella Immunopharma Inc